Cancers, Vol. 13, Pages 3449: 18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
Cancers, Vol. 13, Pages 3449: 18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
Cancers doi: 10.3390/cancers13143449
Authors:
Montserrat Carles
Tobias Fechter
Anca L. Grosu
Arnd Sörensen
Benedikt Thomann
Raluca G. Stoian
Nicole Wiedenmann
Alexander Rühle
Constantinos Zamboglou
Juri Ruf
Luis Martí-Bonmatí
Dimos Baltas
Michael Mix
Nils H. Nicolay
Tumor hypoxia is associated with radiation resistance and can be longitudinally monitored by 18F-fluoromisonidazole (18F-FMISO)-PET/CT. Our study aimed at evaluating radiomics dynamics of 18F-FMISO-hypoxia imaging during chemo-radiotherapy (CRT) as predictors for treatment outcome in head-and-neck squamous cell carcinoma (HNSCC) patients. We prospectively recruited 35 HNSCC patients undergoing definitive CRT and longitudinal 18F-FMISO-PET/CT scans at weeks 0, 2 and 5 (W0/W2/W5). Patients were classified based on peritherapeutic variations of the hypoxic sub-volume (HSV) size (increasing/stable/decreasing) and location (geographically-static/geographically-dynamic) by a new objective classification parameter (CP) accounting for spatial overlap. Additionally, 130 radiomic features (RF) were extracted from HSV at W0, and their variations during CRT were quantified by relative deviations (∆RF). Prediction of treatment outcome was considered statistically relevant after being corrected for multiple testing and confirmed for...
Source: Cancers - Category: Cancer & Oncology Authors: Montserrat Carles Tobias Fechter Anca L. Grosu Arnd S örensen Benedikt Thomann Raluca G. Stoian Nicole Wiedenmann Alexander R ühle Constantinos Zamboglou Juri Ruf Luis Mart í-Bonmatí Dimos Baltas Michael Mix Nils H. Nicolay Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Head and Neck Cancer | HNSCC | PET Scan | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study